Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 9:54 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2281–2304 of 3,107 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Treatment of depression Clear all

Conditions: Anxiety, Depression, Psychiatric or Mood Diseases or Conditions
Interventions: Animal assisted therapy cohort; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Treatment Resistant Depression
Interventions: Medtronic Activa PC+S System; Device
Lead sponsor: Emory University; Other
Eligibility: 25 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2029
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Depression
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Major Depressive Disorder
Interventions: ALTO-100, Placebo; Drug
Lead sponsor: Alto Neuroscience; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 301 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 34
States / cities: Birmingham, Alabama • Huntsville, Alabama • Chandler, Arizona + 26 more

Conditions: Depression, Anxiety Disorders and Symptoms
Interventions: Amplification of Positivity Training (6 Sessions), Stress Management Training (6 Sessions); Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 55 Years
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Depression
Interventions: L-tyrosine, L-Tryptophan, deplin, Placebo A, Placebo B; Dietary Supplement · Drug · Other
Lead sponsor: John D. Dingell VA Medical Center; Federal
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Depression, Fatigue, Leukemia, Musculoskeletal Complications, Psychosocial Effects of Cancer and Its Treatment
Interventions: Resting vitals, Body Composition, Timed Get-up and Go test (TGUG)., Cardiorespiratory assessment, Handgrip evaluation, Dynamic muscular endurance; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Insomnia, Depression
Interventions: CBT for Insomnia (CBT-I), Sleep Hygiene (SH); Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 12 Years to 19 Years
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Suicide, Suicidal Ideation, Substance-Related Disorders
Interventions: Cognitive Behavioral Therapy (CBT), Supportive Psycho-education (SPC); Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 3
States / cities: Colorado Springs, Colorado • Denver, Colorado • Ann Arbor, Michigan

Conditions: Depression
Interventions: Nexalin Based Trans-Cranial Electrical Stimulation; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Belle Mead, New Jersey

Conditions: Major Depressive Disorder
Interventions: Cariprazine, Placebo, Antidepressant Therapy (ADT); Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 1,022 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 83
States / cities: Tucson, Arizona • Little Rock, Arkansas • Cerritos, California + 68 more

Conditions: HIV Infections, Substance Use
Interventions: Peer Activate-LAI, Standard of Care HIV treatment or prevention with LAI-PrEP/ART; Behavioral · Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 88 Years
Enrollment: 186 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland

Conditions: Major Depressive Disorder
Interventions: Escitalopram Pill, Placebo, Levomilnacipran Pill; Drug · Other
Lead sponsor: Howard Aizenstein; Other
Eligibility: 60 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Lung Diseases, Medication Compliance
Interventions: Fluticasone propionate 230mcg for 3 Months, Current Treatment or no treatment, Salmeterol 21mcg for 3 Months; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: PrEP Uptake Experiences, PrEP Adherence Experiences, Mental Health Symptoms
Interventions: Trans STAIR, PrEP Well; Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Depression, Dementia
Interventions: Escitalopram, Donepezil, Venlafaxine, Placebo, Duloxetine; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 65 Years and older
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Major Depressive Disorder (MDD)
Interventions: CTC-501; Drug
Lead sponsor: Chase Therapeutics Corporation; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Long Beach, California

Conditions: Cancer
Interventions: Baseline Participant Assessment, Baseline Healthcare Provider Assessment, Follow-up Participant Assessment, Follow-up Healthcare Provider Assessment, End-of-study Participant Assessment, End-of-study Healthcare Provider Assessment; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 65 Years and older
Enrollment: 227 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Depression
Interventions: Galantamine, Escitalopram; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Urologic Cancer
Interventions: Guided Meditation; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Parkinson's Disease
Interventions: Deep Brain Stimulation; Procedure
Lead sponsor: Vanderbilt University; Other
Eligibility: 50 Years to 85 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Cocaine Dependence, Depression
Interventions: Placebo, Mirtazapine; Other · Drug
Lead sponsor: Boston University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Attention Concentration Difficulty, Depression, Anxiety
Interventions: EVO Cognitive Remediation Game; Other
Lead sponsor: University of Washington; Other
Eligibility: Not listed
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Major Depressive Disorder
Interventions: Combination use of MBCT and IV Ketamine; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Search by objective public record fields.

The Effects of Animal Assisted Therapy in Outpatient Psychiatry Clinics

Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S

Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as Adjuvant Treatment for Depression

Phase 2b Study of ALTO-100 in MDD

Amplification of Positivity to Enhance Social Connections in Anxiety and Depression

Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.

Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic Leukemia

CBT Insomnia Teens: Augmenting SSRIs to Improve Youth Depression

Intervening to Reduce Suicide Risk in Veterans With Substance Use Disorders

The Safety and Efficacy of Nexalin Trans-cranial Electrical Stimulation Stimulation for the Treatment of Depression

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)

Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)

Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program

Trans STAIR: Implementing an Evidence Based Trauma Treatment With Community Led PrEP Navigation

Antidepressant Medication Plus Donepezil for Treating Late-life Depression

A Study in Patients With Major Depressive Disorder

Optimizing Fall-risk Prediction in Older Adults With Cancer

Galantamine Augmentation of Escitalopram for Treatment of Depression

Preoperative Guided Imagery in Patients Undergoing Urologic Surgery

Effect of Deep Brain Stimulation on Depression and Quality of Life in Parkinson's Patients

Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects

Training Resiliency in Youth (TRY) Study

Ketamine-Assisted Mindfulness-Based Cognitive Therapy for Depression: A Pilot Study